Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Minority Interest (2024 - 2025)

Coeptis Therapeutics Holdings (COEP) has 2 years of Minority Interest data on record, last reported at $551195.0 in Q3 2025.

  • For Q3 2025, Minority Interest rose 249.56% year-over-year to $551195.0; the TTM value through Sep 2025 reached $551195.0, up 249.56%, while the annual FY2024 figure was $485102.0, N/A changed from the prior year.
  • Minority Interest reached $551195.0 in Q3 2025 per COEP's latest filing, down from $984300.0 in the prior quarter.
  • Across five years, Minority Interest topped out at $984300.0 in Q1 2025 and bottomed at $132494.0 in Q2 2024.